Traverse Biosciences' Grant

Traverse Biosciences raised a round of funding on June 06, 2014. Investors include Accelerate Long Island.

Traverse Biosciences is commercializing an edible prescription medication for the prevention and control of canine periodontal disease, which affects approximately 80% of dogs over the age of two.…

Articles about Traverse Biosciences' Grant: